Stocks and Investing Stocks and Investing
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (ZVIA) at Buy with Decreased Target to $5 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Bobby Griffin Maintained (AAP) at Strong Buy with Decreased Target to $180 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Steven Zaccone Maintained (AAP) at Hold with Decreased Target to $153 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AAP) at Hold with Decreased Target to $155 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Michael Baker Maintained (AAP) at Hold with Decreased Target to $142 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Scot Ciccarelli Maintained (AAP) at Hold with Decreased Target to $144 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Joseph Bonner Maintained (ADSK) at Strong Buy with Decreased Target to $265 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Nathan Rich Maintained (XRAY) at Hold with Increased Target to $39 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Gaurav Mehta Reiterated (WSR) at Strong Buy and Held Target at $13 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Tim Moore Reiterated (XPEL) at Strong Buy and Held Target at $104 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Heather Balsky Maintained (VRSK) at Sell and Held Target at $167 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Noah Kaye Upgraded (VTNR) to Buy and Held Target at $14 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Amit Dayal Reiterated (VTNR) at Strong Buy and Held Target at $15 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (WRBY) at Buy with Decreased Target to $19 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Paul Lejuez Downgraded (WRBY) to Hold and Decreased Target to $13 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Mark Altschwager Maintained (WRBY) at Buy with Decreased Target to $20 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Vamil Divan Initiated (ANIP) at Strong Buy and Held Target at $55 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Reiterated (ANF) at Buy and Held Target at $33 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Timothy Wojs Maintained (AMWD) at Hold with Increased Target to $58 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Craig Irwin Upgraded (AMRC) to Hold and Held Target at $44 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Joshua Long Reiterated (WEN) at Buy and Held Target at $27 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Sarang Vora Reiterated (WEST) at Buy and Held Target at $15 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Laura Martin Reiterated (VZIO) at Strong Buy and Held Target at $11 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Nicholas Zangler Maintained (VZIO) at Buy with Decreased Target to $17 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Sami Badri Reiterated (WDAY) at Hold and Held Target at $195 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (VEEV) at Strong Buy with Decreased Target to $200 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Jason Celino Maintained (SMAR) at Buy with Increased Target to $48 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Gabe Daoud Downgraded (SM) to Hold and Held Target at $35 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Edward White Reiterated (SNDX) at Strong Buy and Held Target at $33 on, Mar 1st, 2023
[ 12:00 AM ] - WOPRAI
Madhu Kumar Maintained (SNDX) at Strong Buy with Decreased Target to $34 on, Mar 1st, 2023

Madhu Kumar Maintained (SNDX) at Strong Buy with Decreased Target to $34 on, Mar 1st, 2023


Published on 2024-10-28 02:01:17 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Goldman Sachs, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $39 to $34 on, Mar 1st, 2023.

Madhu has made no other calls on SNDX in the last 4 months.



There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with Madhu's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Madhu

  • Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $37 on, Tuesday, January 31st, 2023
  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $41 on, Tuesday, January 3rd, 2023
Contributing Sources